Major vaccine exporters

Major vaccine exporters

Major vaccine exporters

The rate of vaccination depends on the rate of vaccine development and production, and also on a smooth vaccination roll-out. COVAX has invested more than €1 000 million in research and development of new vaccines. This also includes a market place managed by CEPI, that has helped address bottlenecks in the production of the some 200 components required to produce a vaccine.


Related Articles

Be the first to write a comment.

Leave a Reply